• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

适体:疾病诊断与治疗的设计、理论及应用

Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases.

作者信息

Hassibian Sepideh, Amin Mahsa, Taghdisi Seyed Mohammad, Sameiyan Elham, Ghaffari Reza, Alibolandi Mona, Ramezani Mohammad, Abnous Khalil, Dehnavi Seyed Mohsen

机构信息

Department of Cell and Molecular Biology Faculty of Life Science and Biotechnology Shahid Beheshti University Tehran Iran.

Targeted Drug Delivery Research Center Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran.

出版信息

MedComm (2020). 2025 May 19;6(5):e70180. doi: 10.1002/mco2.70180. eCollection 2025 May.

DOI:10.1002/mco2.70180
PMID:40391083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086380/
Abstract

Single-stranded DNA or RNA entities referred to as aptamers exhibit a strong affinity and specificity for attaching to specific targets. Owing to their special properties, which include simplicity of synthesis, low immunogenicity, and adaptability in targeting a variety of substances, these synthetic oligonucleotides have garnered a lot of interest. The function of aptamers can be altered by combining them with complementary oligonucleotides "antidotes," which are antisense to a particular aptamer sequence. Antidotes play an important role in several fields by specifically targeting the corresponding section of the aptamer. Nevertheless, even with their promising capabilities, the creation of antidotes to regulate or inhibit aptamer function continues to be a relatively unexamined field, constraining their secure and efficient application in medical environments. The review explores experimental methodologies for creating antidotes, the systematic design strategies for managing antidotes in aptamer-based therapies, and their therapeutic efficacy in counteracting disease biomarkers. Additionally, it highlights their diagnostic applications in biosensing and imaging, offering a promising alternative to traditional antibodies. It also investigates the progress, latest innovations, and potential medical uses of aptamer-antidote combinations. Its academic value lies in bridging the gap between theoretical design and practical applications, providing researchers and clinicians with a comprehensive resource to advance aptamer-based solutions in medicine and biotechnology.

摘要

被称为适体的单链DNA或RNA实体对附着特定靶标表现出很强的亲和力和特异性。由于其特殊性质,包括合成简单、免疫原性低以及能够靶向多种物质,这些合成寡核苷酸引起了广泛关注。通过将适体与互补寡核苷酸“解毒剂”结合,可以改变适体的功能,这种解毒剂与特定适体序列呈反义关系。解毒剂通过特异性靶向适体的相应部分,在多个领域发挥重要作用。然而,尽管它们具有令人期待的能力,但开发用于调节或抑制适体功能的解毒剂仍然是一个相对未被充分研究的领域,这限制了它们在医疗环境中的安全有效应用。本综述探讨了制备解毒剂的实验方法、基于适体疗法中管理解毒剂的系统设计策略,以及它们在对抗疾病生物标志物方面的治疗效果。此外,还强调了它们在生物传感和成像中的诊断应用,为传统抗体提供了一种有前景的替代方案。同时研究了适体 - 解毒剂组合的进展、最新创新以及潜在的医学用途。其学术价值在于弥合理论设计与实际应用之间的差距,为研究人员和临床医生提供全面的资源,以推动医学和生物技术中基于适体的解决方案的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e7d131e5c7de/MCO2-6-e70180-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e7b0f12641bb/MCO2-6-e70180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e3b1ad537e86/MCO2-6-e70180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/9451ba382b8b/MCO2-6-e70180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/5b2d96e2e0fe/MCO2-6-e70180-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/0600042773d4/MCO2-6-e70180-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e0960f9b9f7a/MCO2-6-e70180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/18ba0cfd82e8/MCO2-6-e70180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e7d131e5c7de/MCO2-6-e70180-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e7b0f12641bb/MCO2-6-e70180-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e3b1ad537e86/MCO2-6-e70180-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/9451ba382b8b/MCO2-6-e70180-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/5b2d96e2e0fe/MCO2-6-e70180-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/0600042773d4/MCO2-6-e70180-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e0960f9b9f7a/MCO2-6-e70180-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/18ba0cfd82e8/MCO2-6-e70180-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b8c/12086380/e7d131e5c7de/MCO2-6-e70180-g009.jpg

相似文献

1
Aptamers: Design, Theory, and Applications to Diagnosis and Therapy for Diseases.适体:疾病诊断与治疗的设计、理论及应用
MedComm (2020). 2025 May 19;6(5):e70180. doi: 10.1002/mco2.70180. eCollection 2025 May.
2
An overview of aptamer: Design strategy, prominent applications, and potential challenge in plants.适体概述:设计策略、在植物中的突出应用及潜在挑战。
J Plant Physiol. 2024 May;296:154235. doi: 10.1016/j.jplph.2024.154235. Epub 2024 Mar 19.
3
Rapid Complexation of Aptamers by Their Specific Antidotes.适配体与其特异性解毒剂的快速复合。
Molecules. 2017 Jun 8;22(6):954. doi: 10.3390/molecules22060954.
4
Antidote control of aptamer therapeutics: the road to a safer class of drug agents.抗体解毒剂控制适体疗法:通往更安全药物制剂的道路。
Curr Pharm Biotechnol. 2012 Aug;13(10):1924-34. doi: 10.2174/138920112802273137.
5
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells.用解毒寡核苷酸或核酸酶进行可逆适体染色、分选和细胞清洗(Clean FACS)可得到完全响应的细胞。
Nucleic Acid Ther. 2024 Feb;34(1):12-17. doi: 10.1089/nat.2023.0050. Epub 2024 Jan 30.
6
Development of universal antidotes to control aptamer activity.开发通用解毒剂以控制适配体活性。
Nat Med. 2009 Oct;15(10):1224-8. doi: 10.1038/nm.1990. Epub 2009 Oct 4.
7
Progress in Aptamer Research and Future Applications.适体研究进展与未来应用
ChemistryOpen. 2025 Feb 3:e202400463. doi: 10.1002/open.202400463.
8
Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer.多价核酸适体及其活性调节:以凝血酶结合适体为例。
Pharmacol Ther. 2012 Nov;136(2):202-15. doi: 10.1016/j.pharmthera.2012.07.011. Epub 2012 Jul 28.
9
Oligonucleotide aptamers: new tools for targeted cancer therapy.寡核苷酸适体:靶向癌症治疗的新工具。
Mol Ther Nucleic Acids. 2014 Aug 5;3(8):e182. doi: 10.1038/mtna.2014.32.
10
Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.基于适体的应用在乳腺癌中的进展:药物传递、治疗和诊断。
Int J Mol Sci. 2022 Nov 21;23(22):14475. doi: 10.3390/ijms232214475.

本文引用的文献

1
Low cluster of differentiation 4+ T-cell count associated with thrombocytopenia among people living with human immunodeficiency virus-1 receiving antiretroviral in West Papua.在西巴布亚接受抗逆转录病毒治疗的人类免疫缺陷病毒1型感染者中,低分化簇4 + T细胞计数与血小板减少有关。
J Med Microbiol. 2025 Jan;74(1). doi: 10.1099/jmm.0.001958.
2
A smart responsive NIR-operated chitosan-based nanoswitch to induce cascade immunogenic tumor ferroptosis via cytokine storm.一种智能响应型近红外操作的壳聚糖基纳米开关,通过细胞因子风暴诱导级联免疫原性肿瘤铁死亡。
Carbohydr Polym. 2025 Mar 1;351:123120. doi: 10.1016/j.carbpol.2024.123120. Epub 2024 Dec 5.
3
Recent Advances in Biosensors Based on Hybridization Chain Reaction and Silver Nanoclusters.
基于杂交链式反应和银纳米簇的生物传感器的最新进展
Small Methods. 2025 Apr;9(4):e2401436. doi: 10.1002/smtd.202401436. Epub 2025 Jan 5.
4
Low background catalytic redox recycling coupled with hybridization chain reaction amplification for highly sensitive electrochemical aptamer luteinizing hormone assay.低背景催化氧化还原循环与杂交链式反应扩增相结合用于高灵敏度电化学适体促黄体生成素检测
Bioelectrochemistry. 2025 Jun;163:108888. doi: 10.1016/j.bioelechem.2024.108888. Epub 2024 Dec 26.
5
Signal-on lateral flow immunoassays for rapid detection of tetrodotoxin in pufferfish.用于快速检测河豚中毒素的信号开启型侧向流动免疫分析方法。
J Hazard Mater. 2025 Mar 15;486:136973. doi: 10.1016/j.jhazmat.2024.136973. Epub 2024 Dec 24.
6
New insights into the role of mitophagy related gene affecting the metastasis of osteosarcoma through scRNA-seq and CRISPR-Cas9 genome editing.通过单细胞RNA测序和CRISPR-Cas9基因组编辑对线粒体自噬相关基因在骨肉瘤转移中作用的新见解。
Cell Commun Signal. 2024 Dec 18;22(1):592. doi: 10.1186/s12964-024-01989-w.
7
Recent Advances and Prospects in RNA Drug Development.RNA 药物研发的最新进展与展望。
Int J Mol Sci. 2024 Nov 15;25(22):12284. doi: 10.3390/ijms252212284.
8
Aptamer-functionalized nucleic acid nanotechnology for biosensing, bioimaging and cancer therapy.适体功能化核酸纳米技术用于生物传感、生物成像和癌症治疗。
Nanoscale. 2025 Jan 2;17(2):687-704. doi: 10.1039/d4nr04360j.
9
DNA-amphiphilic nanostructures: synthesis, characterization and applications.DNA两亲性纳米结构:合成、表征及应用
Nanoscale. 2024 Dec 19;17(1):18-52. doi: 10.1039/d4nr03236e.
10
Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN.2022 年全球肺癌负担及 2050 年预测:全球癌症观测站(GLOBOCAN)的发病率和死亡率估计。
Cancer Epidemiol. 2024 Dec;93:102693. doi: 10.1016/j.canep.2024.102693. Epub 2024 Nov 13.